Anticancer Drug Clustering Based on Proteomic Profiles and a Sensitivity Database in a Lung Cancer Cell Line Panel

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm_00000007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Guide to the Quantitative Proteomic Profiles of the Cancer Cell Line Encyclopedia

2020English

Influence of EGFR-activating Mutations on Sensitivity to Tyrosine Kinase Inhibitors in a KRAS Mutant Non-Small Cell Lung Cancer Cell Line

PLoS ONE
Multidisciplinary
2020English

Cell Line Screens Identify Biomarkers of Drug Sensitivity

Cancer Discovery
Oncology
2012English

Protein Tyrosine Kinase Panel as a Tool for Anticancer Drug Design

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2009English

Characterisation of a Human Small-Cell Lung Cancer Cell Line Resistant to the DNA Topoisomerase I-Directed Drug Topotecan

British Journal of Cancer
Cancer ResearchOncology
1995English

Cell Line Modeling to Study Biomarker Panel in Prostate Cancer

Prostate
OncologyUrology
2015English

A Hyposensitive Anticancer Drug Induces Higher Surface Expression and Release of Heat Shock Proteins in a Human Hepatocellular Carcinoma Cell Line

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: A Resource for Veterinary Drug Discovery, Comparative Oncology and Translational Medicine

Veterinary and Comparative Oncology
Veterinary
2016English

A Study on the Sensitivity Test of Cancer Cells to Anticancer Drugs

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1966English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy